SpringWorks Therapeutics | 8-K: SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
SpringWorks Therapeutics | 10-Q: Q3 2024 Earnings Report
SpringWorks Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Aaron I. Davis(4.6%),Boxer Capital Management, LLC(4.6%), etc.
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lin Tai-An
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Islam Saqib
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Edris Badreddin
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cassidy James
SpringWorks Therapeutics | 8-K: SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
SpringWorks Therapeutics | 10-Q: Q2 2024 Earnings Report
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MACKAY MARTIN
SpringWorks Therapeutics | 3: Initial statement of beneficial ownership of securities-Director MACKAY MARTIN
SpringWorks Therapeutics | 8-K: Current report
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cassidy James
SpringWorks Therapeutics | 8-K: Current report
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Edris Badreddin
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hambleton Julie
SpringWorks Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Islam Saqib
SpringWorks Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data
No Data